AIDS News and Research

RSS

Elizabeth Glaser foundation awarded $45M grant to address pediatric HIV/AIDS in Zimbabwe

The Government of Zimbabwe's national program to eliminate pediatric HIV/AIDS has received a significant boost with an award by the London-based Children's Investment Fund Foundation (CIFF) to the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF).

20 Jan 2011

FDA provides tentative approval under PEPFAR for Matrix's Lamivudine and Zidovudine NDA

Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its New Drug Application (NDA) for Lamivudine and Zidovudine Tablets, 30 mg/60 mg.

20 Jan 2011

HIV-infected patients three times more likely to suffer strokes

While the overall hospitalization rate for stroke has declined in recent years, the numbers have jumped dramatically for patients infected with human immunodeficiency virus (HIV), suggesting they may be up to three times more likely to suffer a stroke than people uninfected by the virus that causes AIDS.

20 Jan 2011

Model guides creation of more patient-centered personal health records

Personal health records have great potential to help patients manage their health, but technology needs to be designed with the patient in mind - which means doing more than helping patients access health information, according to an editorial by two Virginia Commonwealth University family medicine physicians published in the Jan.19 issue of the Journal of the American Medical Association.

20 Jan 2011

BI refuses to offer increased access to AIDS drugs for low-income Americans

AHF issued the following: Despite a growing national AIDS drug crisis, pharmaceutical giant Boehringer Ingelheim Pharmaceuticals, has steadfastly refused to offer increased access to its lifesaving AIDS drugs or to respond in any way to repeated requests by AIDS Healthcare Foundation, the largest global AIDS organization, to do its part in creating a solution.

20 Jan 2011

Koronis' KP-1461 drug causes extra mutations to occur in HIV genome in HIV-infected patients

Recently published Phase 2a clinical trial results show that the frequency of specific, drug-induced mutations in the HIV genome can be significantly increased by administering KP-1461, a drug being developed by Koronis Pharmaceuticals based on its novel Viral Decay Acceleration (VDA) drug mechanism.

20 Jan 2011

UMB enters license agreement with Bali BioSciences for new strategy to combat sepsis, HIV/AIDS

The University of Maryland, Baltimore's (UMB) Office of Technology Transfer has completed a license agreement with Bali BioSciences LLC, an early-stage company pursuing an unusual, yet clever, strategy to combat disease.

20 Jan 2011

DARPA grants $5.6 million to Dana-Farber to develop viable countermeasures against unknown pathogen

Researchers at Dana-Farber Cancer Institute have received a $5.6 million grant from the Defense Advanced Research Projects Agency and the Army Research Office to develop transient immunity against known, unknown, naturally occurring, or engineered disease-causing pathogens.

20 Jan 2011

Autism Speaks Autism Treatment Network adds 17 sites in Canada and the U.S

Autism Speaks and Autism Speaks Canada who together form North America's largest autism science and advocacy organization, is pleased to announce the expansion of its Autism Treatment Network to include 17 leading children's hospitals and academic medical centers in the Canada and the U.S.

20 Jan 2011

Study: HIV-positive head and neck cancer patients respond well to radiation therapy treatments

HIV-positive head and neck cancer patients respond well to radiation therapy treatments and experience similar toxicity rates as non-HIV-positive patients, despite prior reports to the contrary, according to a study in the January issue of the International Journal of Radiation Oncology•Biology•Physics, an official journal of the American Society for Radiation Oncology.

19 Jan 2011

Race and region play major role in health outcomes of people infected with HIV

Women, nonwhites, and people in the southern United States who were newly infected with HIV and followed for an average of four years experienced greater HIV/AIDS-related morbidity compared to men and people of other races living in other regions of the country. The findings, published in the February 15 issue of The Journal of Infectious Diseases, underscore the urgent need to improve the health of these populations in order to reduce HIV-related morbidity and mortality in the U.S.

19 Jan 2011

Researchers create biyouyanagin compound library

Using chemical compounds found in a Japanese plant as a lead and the clever application of ultraviolet light, a Scripps Research Institute team has created a unique library of dozens of synthetic compounds to test for biomedical potential. Already, one of the compounds has shown great promise in inhibiting replication of HIV particles and fighting inflammation.

19 Jan 2011

New project on developing countermeasures for natural and intentional exposure to disease pathogens

Researchers at Dana-Farber Cancer Institute have received a $5.6 million grant from the Defense Advanced Research Projects Agency (DARPA) and the Army Research Office (ARO) to develop transient immunity against known, unknown, naturally occurring, or engineered disease-causing pathogens. The ultimate goal is to develop a viable countermeasure to an unknown pathogen within seven days of receiving it in a laboratory.

19 Jan 2011

WHO Director-General opens executive board session with calls for reform

Kicking off a nine-day annual WHO executive board meeting Monday, WHO Director-General Margaret Chan called for the board to consider areas where the agency can redirect resources in a more targeted manner so as to achieve greater outcomes, Reuters reports.

19 Jan 2011

AMBR sensor measures growth and drug susceptibility of bacterial cells without use of microscope

With an invention that can be made from some of the same parts used in CD players, University of Michigan researchers have developed a way to measure the growth and drug susceptibility of individual bacterial cells without the use of a microscope.

19 Jan 2011

Guardian online series explores global health worker issues

The Guardian reports, as part of an online feature about health care workforces worldwide done in association with the Global Health Workforce Alliance (GHWA), that "Africa is desperately short of doctors and nurses. So is much of Asia. In 57 countries, the situation is deemed by the World Health Organisation (WHO) to be at crisis point ... But in contrast to some other developing world problems, this is an issue that really does affect all of us. The world needs an estimated 4.2 million more health workers."

19 Jan 2011

New York Times examines Russia's 'inadequate fight' against HIV/AIDS

Russia's HIV/AIDS epidemic "has defied worldwide trends, expanding more rapidly year by year than almost anywhere else," the New York Times writes in an article that examines how the country has become "one of the world's low points in the effort to fight the spread of HIV," in large part due to the government's failure to reach out to injecting drug users (IDUs) and sex workers - the groups "at the heart" of the epidemic.

18 Jan 2011

Transcept announces Intermezzo NDA resubmission for treatment of middle of the night awakenings

Transcept Pharmaceuticals, Inc. today announced that it has resubmitted its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval of Intermezzo® for use as needed for the treatment of insomnia when a middle of the night awakening is followed by difficulty returning to sleep.

18 Jan 2011

Clinical studies by expert HIV clinicians suggest that HIV-TRePS may have clinical and economic benefits

Two multinational clinical studies indicate that the RDI’s system for predicting how HIV and AIDS patients will respond to different drugs could be a useful tool with potential clinical and economic benefits. The studies, published in the January issue of AIDS Patient Care and STDs, involved highly experienced physicians in the USA, Canada and Italy who used the system to help them select the optimum combination of HIV drugs for patients whose therapy was failing.

18 Jan 2011

Opinions: U.S. HIV funding; Global fund accountability; World food supply

President Barack Obama's Global Health Initiative is "pitting AIDS against other diseases by making investments in new areas of global health contingent on flat funding for efforts to fight the HIV epidemic," HIV/AIDS advocate and Yale College student Gregg Gonsalves writes in a Washington Post opinion piece.

18 Jan 2011

AIDS News and Research

Elizabeth Glaser foundation awarded $45M grant to address pediatric HIV/AIDS in Zimbabwe

FDA provides tentative approval under PEPFAR for Matrix's Lamivudine and Zidovudine NDA

HIV-infected patients three times more likely to suffer strokes

Model guides creation of more patient-centered personal health records

BI refuses to offer increased access to AIDS drugs for low-income Americans

Koronis' KP-1461 drug causes extra mutations to occur in HIV genome in HIV-infected patients

UMB enters license agreement with Bali BioSciences for new strategy to combat sepsis, HIV/AIDS

DARPA grants $5.6 million to Dana-Farber to develop viable countermeasures against unknown pathogen

Autism Speaks Autism Treatment Network adds 17 sites in Canada and the U.S

Study: HIV-positive head and neck cancer patients respond well to radiation therapy treatments

Race and region play major role in health outcomes of people infected with HIV

Researchers create biyouyanagin compound library

New project on developing countermeasures for natural and intentional exposure to disease pathogens

WHO Director-General opens executive board session with calls for reform

AMBR sensor measures growth and drug susceptibility of bacterial cells without use of microscope

Guardian online series explores global health worker issues

New York Times examines Russia's 'inadequate fight' against HIV/AIDS

Transcept announces Intermezzo NDA resubmission for treatment of middle of the night awakenings

Clinical studies by expert HIV clinicians suggest that HIV-TRePS may have clinical and economic benefits

Opinions: U.S. HIV funding; Global fund accountability; World food supply

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News